![Michael S. Eison](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Michael S.
Eison worked as a Vice President in Regulatory Affairs and Research & Development at various pharmaceutical companies including Synosia Therapeutics, Stiefel Laboratories, and Connetics Corp.
He also worked as a Senior Director in Regulatory Affairs at InterMune, Inc. and as a Director in CNS Drug Discovery at Bristol Myers Squibb Co. Eison holds a doctorate degree from the University of California, Los Angeles and an undergraduate degree from The State University of New York.
Ehemalige bekannte Positionen von Michael S. Eison
| Unternehmen | Position | Ende |
|---|---|---|
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | General Counsel | 14.04.2011 |
Synosia Therapeutics, Inc.
 Synosia Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops products for unmet medical needs in psychiatry and neurology | Public Communications Contact | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| INTERMUNE INC | General Counsel | - |
Stiefel Laboratories, Inc.
 Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Michael S. Eison
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
92
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Synosia Therapeutics AG
 Synosia Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of psychiatry and neurology diseases | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The State University of New York
 The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synosia Therapeutics, Inc.
Synosia Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops products for unmet medical needs in psychiatry and neurology | Health Technology |
Wählen Sie MarketScreener 
